[First experience of using modified high-dose therapy NHL-BFM-90 in diffuse large B-cell lymphosarcoma with primary skin involvement. A case report].

Autor: Zamiatina VI, Magomedova AU, Kravchenko SK, Giliazitdinova EA, Iliushkina EA, Zvonkov EE, Kaplanskaia IB, Obukhova TN, Kliasova GA, Gorgidze LA, Churakova ZhV, Kremenetskaia AM, Vorob'ev AI
Jazyk: ruština
Zdroj: Terapevticheskii arkhiv [Ter Arkh] 2009; Vol. 81 (7), pp. 71-5.
Abstrakt: Primary skin large B-cell lymphosarcomas (PLBCL) present with skin lesions, other organs and systems are not involved. As CHOP courses are not high effective in PLBCL, we were the first to treat a patient with modified block therapy NHL BFM-90. A complete remission was achieved after the first course of polychemotherapy and was consolidated by two courses of treatment. Further follow-up is needed.
Databáze: MEDLINE